Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Lucarelli

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Diagnostics (Basel, Switzerland)|December 16, 2020
CRMS/CFSPID Subjects Carrying D1152H CFTR Variant: Can the Second Variant Be a Predictor of Disease Development?Vito Terlizzi, Rita Padoan, Laura Claut, et al.
The Journal of Molecular Diagnostics : JMD|July 25, 2017
A New Targeted CFTR Mutation Panel Based on Next-Generation Sequencing TechnologyMarco Lucarelli, Luigi Porcaro, Alice Biffignandi, et al.
Molecular Medicine (Cambridge, Mass.)|April 25, 2015
A Genotypic-Oriented View of CFTR Genetics Highlights Specific Mutational Patterns Underlying Clinical Macrocategories of Cystic FibrosisMarco Lucarelli, Sabina Maria Bruno, Silvia Pierandrei, et al.
Plos One|April 25, 2013
Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patientsSerena Schippa, Valerio Iebba, Floriana Santangelo, et al.
Frontiers in Neurology|November 18, 2016
A Novel Mutation in <i>ABCA1</i> Gene Causing Tangier Disease in an Italian Family with Uncommon Neurological PresentationMarco Ceccanti, Chiara Cambieri, Vittorio Frasca, et al.
Current Issues in Molecular Biology|February 23, 2024
Nerve Growth Factor and the Role of Inflammation in Tumor DevelopmentGiampiero Ferraguti, Sergio Terracina, Luigi Tarani, et al.
Plos One|April 22, 2015
Atherogenic dyslipidemia in children: evaluation of clinical, biochemical and genetic aspectsAnna Montali, Gessica Truglio, Francesco Martino, et al.
Biomedicines|May 16, 2023
Urine Dipstick Analysis on Automated Platforms: Is a Reliable Screening Tool for Proteinuria? An Experience from Umberto I Hospital in RomeSergio Terracina, Antonio Pallaria, Marco Lucarelli, et al.
Plos One|July 16, 2015
Correction: Atherogenic Dyslipidemia in Children: Evaluation of Clinical, Biochemical and Genetic AspectsAnna Montali, Gessica Truglio, Francesco Martino, et al.
Breast Cancer (Tokyo, Japan)|October 13, 2025
Is there an impact of autoimmune rheumatological diseases on cutaneous toxicity in breast cancer adjuvant radiotherapy? A mono-institutional experienceGiulia de Pasquale, Valeria Donatiello, Marco Lucarelli, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Diagnostics (Basel, Switzerland)|December 16, 2020
CRMS/CFSPID Subjects Carrying D1152H CFTR Variant: Can the Second Variant Be a Predictor of Disease Development?Vito Terlizzi, Rita Padoan, Laura Claut, et al.
The Journal of Molecular Diagnostics : JMD|July 25, 2017
A New Targeted CFTR Mutation Panel Based on Next-Generation Sequencing TechnologyMarco Lucarelli, Luigi Porcaro, Alice Biffignandi, et al.
Molecular Medicine (Cambridge, Mass.)|April 25, 2015
A Genotypic-Oriented View of CFTR Genetics Highlights Specific Mutational Patterns Underlying Clinical Macrocategories of Cystic FibrosisMarco Lucarelli, Sabina Maria Bruno, Silvia Pierandrei, et al.
Plos One|April 25, 2013
Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patientsSerena Schippa, Valerio Iebba, Floriana Santangelo, et al.
Frontiers in Neurology|November 18, 2016
A Novel Mutation in <i>ABCA1</i> Gene Causing Tangier Disease in an Italian Family with Uncommon Neurological PresentationMarco Ceccanti, Chiara Cambieri, Vittorio Frasca, et al.
Current Issues in Molecular Biology|February 23, 2024
Nerve Growth Factor and the Role of Inflammation in Tumor DevelopmentGiampiero Ferraguti, Sergio Terracina, Luigi Tarani, et al.
Plos One|April 22, 2015
Atherogenic dyslipidemia in children: evaluation of clinical, biochemical and genetic aspectsAnna Montali, Gessica Truglio, Francesco Martino, et al.
Biomedicines|May 16, 2023
Urine Dipstick Analysis on Automated Platforms: Is a Reliable Screening Tool for Proteinuria? An Experience from Umberto I Hospital in RomeSergio Terracina, Antonio Pallaria, Marco Lucarelli, et al.
Plos One|July 16, 2015
Correction: Atherogenic Dyslipidemia in Children: Evaluation of Clinical, Biochemical and Genetic AspectsAnna Montali, Gessica Truglio, Francesco Martino, et al.
Breast Cancer (Tokyo, Japan)|October 13, 2025
Is there an impact of autoimmune rheumatological diseases on cutaneous toxicity in breast cancer adjuvant radiotherapy? A mono-institutional experienceGiulia de Pasquale, Valeria Donatiello, Marco Lucarelli, et al.
Pageof 10